Telo Genomics Corp (TSE:TELO) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Telo Genomics Corp has revealed promising results for its TeloViewSMM prognostic test, which outperformed existing models in identifying high and low-risk smoldering myeloma patients. This innovative test could transform patient management by offering a non-invasive method to monitor disease progression, addressing a significant market opportunity.
For further insights into TSE:TELO stock, check out TipRanks’ Stock Analysis page.